With cases rising again with Omnicron variant, USFDA grants EUA for Roche COVID-19 rapid home diagnostic kit
LONDON, GREATER LONDON, United Kingdom, January 6, 2022 /EINPresswire.com/ – Last days of our annual market report sale! Buy now – https://www.thebusinessresearchcompany.com/global-market-reports
In December 2021, the USFDA granted an Emergency Use Clearance (EUA) for F. Hoffmann-La Roche Ltd’s home COVID-19 test, an over-the-counter diagnostic kit. The COVID-19 At-Home test is a rapid chromatographic immunoassay for the qualitative detection of the core protein of the SARS-CoV-2 virus. The COVID-19 home test uses a simple nasal swab sample to allow individuals to self-test at home and receive accurate, reliable, and rapid results within 20 minutes for SARS-CoV-2 and d ‘other variants, including Omicron.
According to reports from The Business Research Company, demand for COVID19 detection kits will continue to grow due to the increasing incidence of COVID-19 and other variants such as Omicron and the growing demand for COVID-19 detection kits. economical and fast. the Global COVID-19 Detection Test Kits and Consumables Market Size is expected to grow from $ 5.2 billion in 2020 to $ 6.1 billion in 2021 at a compound annual growth rate (CAGR) of 17.3%. The market is further expected to reach $ 8 billion in 2025 at a CAGR of 7.1%. The easing of USFDA regulatory processes for COVID-19 detection kits will also help the market for COVID-19 detection kits and consumables to grow. According to the World Health Organization (WHO), COVID-19 cases increased by 11% globally in December 2021, and Omicron has become the dominant strain in many countries. This is expected to drive demand for COVID-19 detection test kits during the forecast period.
TBRC COVID-19 Rapid Test Kits Market Report is segmented by test type, kit type, sample type, end users and geography
• By type of test: PCR RT test, rapid antigen test, rapid antibody test and others
• By type of kit – PCR machines, extraction equipment and kits, and reagents
• By type of sample: nasopharyngeal swab, oropharyngeal swab, nasal swab, blood and others
• By end users – Hospitals and clinics, diagnostic laboratories, home care and others
• By geography – North America, South America, Asia-Pacific, Western Europe, Eastern Europe, Middle East, Africa
The research comes from the TBRC, FDA reports.
The expected revenue of the company is calculated based on the assumption that the market share of the company will remain the same during the forecast period.
Here are some related reports:
Global Rapid Microbiological Test Kits Market Report 2021 – By Product Type (Instruments, Reagents & Kits, Consumables), By Application (Clinical Disease Diagnosis, Food & Beverage Testing, Pharmaceutical & Biological Drug Testing, Cosmetics and Personal Care Product Testing, Environmental Testing, Research Applications), by test type (growth-based rapid microbiological test kits, cellular component-based rapid microbiological test kits, rapid microbiological test kits based on nucleic acids, rapid microbiological test kits based on viability), growth and change COVID-19
COVID-19 Drug Associated APIs Global Market Report 2021 – By Drug Class (Antimalarials, Bronchodilators, Antibiotics, Antivirals), Growth and Course of COVID-19
About the global market model
The Global Market Model is the world’s most comprehensive database of integrated market information available. The ten year forecast of the global market model is updated in real time to reflect the latest market realities, which is a huge advantage over static reporting based platforms.
Interested in knowing more about The commercial research company?
The Business Research Company is a market intelligence company that excels in business, market and consumer research. With offices around the world, it has consultants who specialize in a wide range of industries, including manufacturing, healthcare, financial services, chemicals and technology. The Global Market Model is The Business Research Company’s flagship product.
The commercial research company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]